Lista de obras - Simona De Summa - Dominio Público Uruguay

A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model

artículo científico publicado en 2017

Adipokines in hereditary breast cancer patients and healthy relatives.

artículo científico publicado en 2017

BRCA Unclassified Variants: How Can They be Classified?

BRCA1-2 diagnostic workflow from next-generation sequencing technologies to variant identification and final report

artículo científico publicado en 2016

BRCAness: a deeper insight into basal-like breast tumors

artículo científico publicado en 2013

Cancer-Associated Angiogenesis: The Endothelial Cell as a Checkpoint for Immunological Patrolling

artículo científico publicado en 2020

Combined microRNA and ER expression: a new classifier for familial and sporadic breast cancer patients

artículo científico publicado en 2014

Comment on 'Renewed interest in the progesterone receptor in breast cancer'.

artículo científico publicado en 2017

Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma

artículo científico publicado en 2020

DHPLC/SURVEYOR nuclease: a sensitive, rapid and affordable method to analyze BRCA1 and BRCA2 mutations in breast cancer families

artículo científico publicado en 2012

DNA methylation and miRNAs regulation in hereditary breast cancer: epigenetic changes, players in transcriptional and post- transcriptional regulation in hereditary breast cancer

artículo científico publicado en 2014

Expression of base excision repair key factors and miR17 in familial and sporadic breast cancer

artículo científico publicado en 2014

GATK hard filtering: tunable parameters to improve variant calling for next generation sequencing targeted gene panel data.

artículo científico publicado en 2017

Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study

artículo científico publicado en 2019

Genetic profiling of a rare condition: co-occurrence of albinism and multiple primary melanoma in a Caucasian family

artículo científico publicado en 2016

Genetic risk transmission in a family affected by familial breast cancer

artículo científico publicado en 2013

HOX gene methylation status analysis in patients with hereditary breast cancer

article

Immunological mutational signature in adenosquamous cancer of pancreas: an exploratory study of potentially therapeutic targets

artículo científico publicado en 2018

Immunoprofile from tissue microarrays to stratify familial breast cancer patients

artículo científico publicado en 2015

Innovative technology for cancer risk analysis.

artículo científico publicado en 2011

Maternal and paternal lineage double heterozygosity alteration in familial breast cancer: a first case report

artículo científico publicado en 2010

MiR-578 and miR-573 as potential players in BRCA-related breast cancer angiogenesis

artículo científico publicado en 2015

MicroRNA expression in BRAF-mutated and wild-type metastatic melanoma and its correlation with response duration to BRAF inhibitors.

artículo científico publicado en 2015

MicroRNA expression profiling in male and female familial breast cancer.

artículo científico publicado en 2014

Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second Line The

artículo científico publicado en 2019

Molecular alterations in basal cell carcinoma subtypes

artículo científico publicado en 2021

Next-generation sequencing: advances and applications in cancer diagnosis

artículo científico publicado en 2016

Nuclear PARP1 expression and its prognostic significance in breast cancer patients.

artículo científico publicado en 2015

P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma

scientific article published on 14 September 2020

Proteomic profile and in silico analysis in metastatic melanoma with and without BRAF mutation

artículo científico publicado en 2014

Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance

artículo científico publicado en 2016

Six low-penetrance SNPs for the estimation of breast cancer heritability: A family-based study in Caucasian Italian patients

artículo científico publicado en 2017

The next generation of metastatic melanoma: uncovering the genetic variants for anti-BRAF therapy response

artículo científico publicado en 2016

The value of new high-throughput technologies for diagnosis and prognosis in solid tumors

artículo científico publicado en 2014

Unclassified variants in BRCA genes: guidelines for interpretation

article

VEGF and TWIST1 in a 16-biomarker immunoprofile useful for prognosis of breast cancer patients.

artículo científico publicado en 2017

miR-151-5p, targeting chromatin remodeler SMARCA5, as a marker for the BRCAness phenotype

artículo científico publicado en 2016

miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcome

artículo científico publicado en 2015

u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression

artículo científico publicado en 2017

Lista de obras de Simona De Summa

A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model

Adipokines in hereditary breast cancer patients and healthy relatives.

BRCA Unclassified Variants: How Can They be Classified?

BRCA1-2 diagnostic workflow from next-generation sequencing technologies to variant identification and final report

BRCAness: a deeper insight into basal-like breast tumors

Cancer-Associated Angiogenesis: The Endothelial Cell as a Checkpoint for Immunological Patrolling

Combined microRNA and ER expression: a new classifier for familial and sporadic breast cancer patients

Comment on 'Renewed interest in the progesterone receptor in breast cancer'.

Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma

DHPLC/SURVEYOR nuclease: a sensitive, rapid and affordable method to analyze BRCA1 and BRCA2 mutations in breast cancer families

DNA methylation and miRNAs regulation in hereditary breast cancer: epigenetic changes, players in transcriptional and post- transcriptional regulation in hereditary breast cancer

Expression of base excision repair key factors and miR17 in familial and sporadic breast cancer

GATK hard filtering: tunable parameters to improve variant calling for next generation sequencing targeted gene panel data.

Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study

Genetic profiling of a rare condition: co-occurrence of albinism and multiple primary melanoma in a Caucasian family

Genetic risk transmission in a family affected by familial breast cancer

HOX gene methylation status analysis in patients with hereditary breast cancer

Immunological mutational signature in adenosquamous cancer of pancreas: an exploratory study of potentially therapeutic targets

Immunoprofile from tissue microarrays to stratify familial breast cancer patients

Innovative technology for cancer risk analysis.

Maternal and paternal lineage double heterozygosity alteration in familial breast cancer: a first case report

MiR-578 and miR-573 as potential players in BRCA-related breast cancer angiogenesis

MicroRNA expression in BRAF-mutated and wild-type metastatic melanoma and its correlation with response duration to BRAF inhibitors.

MicroRNA expression profiling in male and female familial breast cancer.

Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second Line The

Molecular alterations in basal cell carcinoma subtypes

Next-generation sequencing: advances and applications in cancer diagnosis

Nuclear PARP1 expression and its prognostic significance in breast cancer patients.

P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma

Proteomic profile and in silico analysis in metastatic melanoma with and without BRAF mutation

Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance

Six low-penetrance SNPs for the estimation of breast cancer heritability: A family-based study in Caucasian Italian patients

The next generation of metastatic melanoma: uncovering the genetic variants for anti-BRAF therapy response

The value of new high-throughput technologies for diagnosis and prognosis in solid tumors

Unclassified variants in BRCA genes: guidelines for interpretation

VEGF and TWIST1 in a 16-biomarker immunoprofile useful for prognosis of breast cancer patients.

miR-151-5p, targeting chromatin remodeler SMARCA5, as a marker for the BRCAness phenotype

miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcome

u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression